Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Clinical trial NCT07070466 · RECRUITING

Trial details

NCT number: NCT07070466
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Cancer Stage IV Esophagus Cancer Stomach Cancer

Start date: 2025-10-10
Primary completion: 2026-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.